Navigating the SAFE vs. iSAFE Instruments: What Every Founder and Investor Needs to Know

February 23, 2026

We are seeing a significant shift in early-stage fundraising as startups move away from complex, long-form agreements toward simpler models like the SAFE and its Indian counterpart, the iSAFE. While these instruments are designed for speed and flexibility, the legal nuances between them carry substantial implications for ownership and regulatory compliance.

Understanding the Instruments

The U.S. SAFE (Simple Agreement for Future Equity), pioneered by Y Combinator in 2013, is a contractual right to receive equity in the future upon a “trigger event,” such as a priced funding round. Crucially, it is not debt; it carries no interest and has no maturity date.

The iSAFE (India SAFE), introduced by 100X.VC in 2019, adapts this concept to the Indian legal landscape. Because Indian law only recognizes specific instruments like equity, preference shares, or debt, the iSAFE is structured as Compulsorily Convertible Preference Shares (CCPS) to ensure enforceability.

Critical Nuances: SAFE vs. iSAFE

Investors and founders must be aware of these fundamental distinctions:

  • Maturity & Duration: While U.S. SAFEs can remain outstanding indefinitely, iSAFEs must have a long-stop date for automatic conversion to comply with Indian statutory requirements.
  • Dividends and Rights: Unlike the U.S. SAFE, which typically offers no immediate rights, iSAFE holders receive a nominal dividend (often 0.0001%) to satisfy CCPS requirements under Indian laws.
  • Liquidation Preference: As preference shareholders, iSAFE holders have statutory preference rights during a liquidation event, whereas U.S. SAFE holders rely purely on contractual terms.

The Dilution Trap: Post-Money SAFEs

Since 2018, the “Post-Money” SAFE has become the industry standard to provide immediate clarity on ownership. However, it presents a unique dilution risk for founders:

  • Fixed Ownership: Post-money SAFEs fix the investor’s ownership percentage before the next priced round.
  • Founder Burden: If a founder raises multiple post-money SAFEs, the dilution from all those instruments — and any expanded option pools — falls entirely on the founders and existing team members, rather than being shared with the SAFE investors.

The Impact of Caps and Discounts

  • Valuation Caps set a maximum conversion price, rewarding early risk-takers. If a startup’s valuation in a later round exceeds the cap, the SAFE investor converts at the lower cap, significantly increasing their ownership stake.
  • Discounts (typically 15–20%) allow investors to buy shares cheaper than later-round participants.
  • The Risk: Without careful modeling, a low valuation cap can lead to extreme dilution for founders if the subsequent round’s valuation is lower than anticipated.

Structuring Issues

Choosing to use a “pure” U.S.-style SAFE in India without structuring it as CCPS invites severe challenges:

  1. Regulatory Limbo: A standalone SAFE does not qualify as a “capital instrument” under RBI and FEMA regulations, making it ineligible for legal foreign investment.
  2. Statutory Non-Compliance: Without being embedded in CCPS, the instrument sits outside the Companies Act, 2013, creating ambiguity regarding its legality and recognition in a company’s books.
  3. Enforceability Risks: A non-CCPS structure could be viewed as an unregulated forward contract, potentially leaving investors with no downside protection if trigger events are never activated.

Conclusion

While iSAFEs offer a fast-track to capital, “standard” templates often require significant modifications of the underlying terms, triggering events and the valuation caps to protect founder equity as well as to ensure compliance with Indian law.